Efficacy and safety of dual vs single renin–angiotensin–aldosterone system blockade in chronic kidney disease: An updated meta-analysis of randomized controlled trials

BACKGROUND: To lower albuminuria and to achieve blood pressure (BP) goals, dual renin–angiotensin–aldosterone system (RAAS) inhibitors are sometimes used in clinical practice for the treatment of CKD. However, the efficacy and safety of dual RAAS blockade therapy remains controversial. METHODS: PubM...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Mingming, Qu, Hua, Wang, Rumeng, Yu, Yi, Chang, Meiying, Ma, Sijia, Zhang, Hanwen, Wang, Yuejun, Zhang, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5200
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415955/
https://www.ncbi.nlm.nih.gov/pubmed/34477114
http://dx.doi.org/10.1097/MD.0000000000026544

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415955/
https://www.ncbi.nlm.nih.gov/pubmed/34477114
http://dx.doi.org/10.1097/MD.0000000000026544

Ejemplares similares